Adverse Drug Reactions Related Hospital Admissions in Persons Aged 60 Years and over, The Netherlands, 1981–2007: Less Rapid Increase, Different Drugs by Hartholt, Klaas A. et al.
Adverse Drug Reactions  Related Hospital Admissions in
Persons Aged 60 Years and over, The Netherlands, 1981–
2007: Less Rapid Increase, Different Drugs
Klaas A. Hartholt
1,2, Nathalie van der Velde
1, Caspar W. N. Looman
3, Martien J. M. Panneman
4, Ed F. van
Beeck
3, Peter Patka
2, Tischa J. M. van der Cammen
1*
1Section of Geriatric Medicine, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands, 2Department of Surgery-
Traumatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands, 3Department of Public Health, Erasmus MC, University Medical Center, Rotterdam,
The Netherlands, Erasmus MC, University Medical Center, Rotterdam, The Netherlands, 4Consumer and Safety Institute, Amsterdam, The Netherlands
Abstract
Background: Epidemiologic information on time trends of Adverse Drug Reactions (ADR) and ADR-related hospitalizations
is scarce. Over time, pharmacotherapy has become increasingly complex. Because of raised awareness of ADR, a decrease in
ADR might be expected. The aim of this study was to determine trends in ADR-related hospitalizations in the older Dutch
population.
Methodology and Principal Findings: Secular trend analysis of ADR-related hospital admissions in patients $60 years
between 1981 and 2007, using the National Hospital Discharge Registry of the Netherlands. Numbers, age-specific and age-
adjusted incidence rates (per 10,000 persons) of ADR-related hospital admissions were used as outcome measures in each
year of the study. Between 1981 and 2007, ADR-related hospital admissions in persons $60 years increased by 143%. The
overall standardized incidence rate increased from 23.3 to 38.3 per 10,000 older persons. The increase was larger in males
than in females. Since 1997, the increase in incidence rates of ADR-related hospitalizations flattened (percentage annual
change 0.65%), compared to the period 1981–1996 (percentage annual change 2.56%).
Conclusion/Significance: ADR-related hospital admissions in older persons have shown a rapidly increasing trend in the
Netherlands over the last three decades with a temporization since 1997. Although an encouraging flattening in the
increasing trend of ADR-related admissions was found around 1997, the incidence is still rising, which warrants sustained
attention to this problem.
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Introduction
Medication use among older persons has grown over the last
decades.[1] Pharmacotherapy has become increasingly com-
plex[2] due to growing knowledge about disease pathophysiology,
discovery of new drug therapies over time, and secondary
preventive therapies, usually laid down in guidelines or proto-
cols.[3] In 2007, persons aged $65 years constituted 14.4% of the
Dutch population, whereas 44% of all drug prescriptions was for
this age-group.[4] This is not surprising, as older persons in
general have the highest prevalence of chronic and multiple (co-
morbid) diseases. However, benefits of medication use are always
accompanied by potential harm. Even when medication is
prescribed in the recommended doses according to the guide-
lines,[3] Adverse Drug Reactions (ADR) can occur. The frequency
of ADR increases with increasing age.[5–8,9] Older adults are at
increased risk of developing an ADR[10] due to their social
setting[11,12], polypharmacy[3,11–15], co-morbidity[16], cogni-
tive impairment[12,15], and physiological changes affecting the
pharmacokinetics and pharmacodynamics of many drugs.
[2,11,17,18]
Recent studies have shown that ADR-related hospital admis-
sions are increasing,[8,19] and account for approximately 5–12%
of all hospital admissions in older patients[6,7,9,11,14,20,21] with
a high in-hospital mortality rate of 8–10%.[9] Furthermore, ADR-
related hospital admissions appear to be preventable in two fifth of
cases.[11,13,20] All in all, ADR in the older population form a
large public healthcare problem, resulting in significant morbidity,
healthcare consumption and high costs. Because of ageing
societies[22] and an increasing life expectancy[23], ADR might
be expected to become even a more serious public health problem.
Since multiple studies on ADR-related hospital admissions in
older persons and their possible preventability have been
performed, awareness on ADR has increased.[24,25] We were
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13977interested in time trends of ADR-related hospitalizations, and
especially whether the increased awareness about ADR has led to
an actual decline of ADR-related hospitalizations. However, there
is a paucity of data on time trends in healthcare use due to
ADR.[26] Therefore, the aim of this study was to provide accurate
data on trends in ADR-related hospitalization in older patients
over the last decades.
Methods
Data on ADR-related hospital admissions were retrieved from
Statistics Netherlands (CBS, The Hague, The Netherlands), which
combines information of the National Medical Registration (LMR)
and the National Hospital Discharge Registry.[27] The LMR
collects hospital data of nearly all hospitals in the Netherlands.
Data regarding hospital admissions, primary admission diagnosis
(i.e., the most dominant reason for admission), gender and age are
stored in this database. Data on hospital admissions, mortality, and
population composition were verified with the official Birth-
registry. The Birth-registry is used to identify individual patients in
the National Medical Registration. Based on specific personal
characteristics, such as date of birth, gender, and address it is
possible to determine individual patients. A uniform classification
and coding system by the LMR is used for all hospitals and has a
high coverage (less than 5% missing between 1981–2005, 12.0%
in 2007). The coding system did not change during the study
period. Extrapolation to full national coverage for each year was
done by Statistics Netherlands. An extrapolation factor was
estimated by comparing the adherence population of the
participating hospitals with the total Dutch population in each
year of the study.[28] Demographic data were also collected from
Statistics Netherlands. The mid-year population number was used
as denominator in this study.
ADR were defined as: ‘‘Medicinal and Biological substances
causing adverse effects in therapeutic use’’, using the International
Classification for Diseases, 9
th revision (ICD-9), code E930 – E949
(Table 1) throughout the study period. The E-codes of the ICD-9
classification are used to describe the external cause of injuries.
Drug-classes used in this study were based on the ICD-9 codes
(E930-E949). Official coding clerks register the diagnosis and
injury mechanism of all hospital admissions, based on data
obtained from medical records. For this study, hospital admissions
in older patients with ADR as the primary admission diagnosis
were collected over the period 1981–2007. Older persons were
defined as persons aged $60 years. Numbers of ADR-related
hospital admissions were specified for age and gender. Age-specific
incidence rates, in 5-year age-groups, were calculated using the
number of the ADR-related hospital admissions in that specific
age-group, divided by the total mid-year population number
within that specific age-group. The age-specific incidence rates
were separated for both genders, and expressed per 10,000 persons
of that specific age-group. Direct standardization, based on the
mean population size per 5-year age-group throughout the study
period, was used to calculate the overall age-adjusted incidence in
males and females. Growth in the number of hospital admissions
was calculated in percentual increases compared to the year 1981.
This model has been used in a previous study.[29]
Statistical analysis
To model the trend in hospital admissions, a regression model
with Poisson error and log link was built with log mid-year
Table 1. International Codes of Diseases of the World Health Organization, 9
th revision, for Adverse Drug Reactions.
Code Description
E930 Antibiotics causing adverse effects in therapeutic use
E931 Other anti-infectives causing adverse effects in therapeutic use
E932 Hormones and synthetic substitutes causing adverse effects in therapeutic use (including a.o. cortical steroids, androgens, ovarian hormones,
insulins, and thyroid derivates)
E933 Primarily systemic agents causing adverse effects in therapeutic use (including a.o. anti-neoplastic, immunosuppressive drugs, bisphosphonates,
vitamins and enzymes)
E934 Agents primarily affecting blood constituents causing adverse effects in therapeutic use (including a.o. anti-coagulants, anti-coagulant
antagonists, anti-anemic agents, iron)
E935 Analgesics antipyretics and anti-rheumatics causing adverse effects in therapeutic use
E936 Anticonvulsants and anti-parkinsonism drugs causing adverse effects in therapeutic use
E937 Sedatives and hypnotics causing adverse effects in therapeutic use
E938 Other central nervous system depressants and anesthetics causing adverse effects in therapeutic use
E939 Psychotropic agents causing adverse effects in therapeutic use
E940 Central nervous system stimulants causing adverse effects in therapeutic use
E941 Drugs primarily affecting the autonomic nervous system causing adverse effects in therapeutic use
E942 Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use
E943 Agents primarily affecting gastrointestinal system causing adverse effects in therapeutic use
E944 Water mineral and uric acid metabolism drugs causing adverse effects in therapeutic use
E945 Agents primarily acting on the smooth and skeletal muscles and respiratory system causing adverse effects in therapeutic use
E946 Agents primarily affecting skin and mucous membrane ophthalmological otorhinolaryngological and dental drugs causing adverse effects in therapeutic use
E947 Other and unspecified drugs and medicinal substances causing adverse effects in therapeutic use
E948 Bacterial vaccines causing adverse effects in therapeutic use
E949 Other vaccines and biological substances causing adverse effects in therapeutic use
doi:10.1371/journal.pone.0013977.t001
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offset factor. A linear spline model, with age, year, gender, and
population size was built to assess whether the annual growth
changed over the study period for both genders. The parameter
for calendar year, corrected for gender and age-group was
transformed into Percentage Annual Change (PAC). Our spline
function accommodated two piecewise linear fits, connected with
one another at the best knot[30], which was estimated with
‘Joinpoint Regression Program’, Version 3.3.1. (Statistical Re-
search and Applications Branch, National Cancer Institute, USA).
This program decided where to place the knot and showed the
necessity for assuming a spline instead of a simple linear model.
The best knot, for males and females together, was found to be
January 1, 1997. Therefore this knot was used for the analysis in
both males and females. The analysis including splines yielded
estimates of annual changes in admission rates within each period
(1981–1996 and 1997–2007 respectively). Comparison of these
two periods enabled us to detect and quantify changes in the
secular trend in overall admission rates. A likelihood ratio test was
performed to assess the significance of the spline over a single
trend for the study period. Interactions of the spline for gender
were added and tested to investigate differences in trends for
genders. A Chi
2-test was used to detect changes in drug-classes and
admission diagnosis. Statistical analyses were performed using
SPSS software (version 16.1.1). A p-value ,0.05 was considered as
statistically significant.
Results
During the 26 years of observation a total of 361,760 ADR-
related hospitalizations were identified in the Netherlands
(Table 2). Over two-thirds of the admissions (247,638) occurred
in persons $60 years, which constituted only 17.6% on average of
the Dutch population over 1981–2007. The total number of ADR-
related hospital admissions in the Dutch population aged $60
years increased from 5,291 admissions in 1981 to 12,836 in 2007
(Figure 1). ADR-related hospitalizations increased by 175% in
males aged $60 years (from 2,056 in 1981 to 5,651 in 2007) and
by 112% in females aged $60 years (from 3,235 in 1981 to 7,185
in 2007). The overall standardized incidence rate (per 10,000
persons) of ADR-related hospital admissions in persons aged 60
years and older increased from 23.3 in 1981 to 38.3 in 2007
(Figure 1). The overall incidence rates (per 10,000 persons)
increased in males from 21.3 in 1981 to 37.5 in 2007 and in
females from 24.8 in 1981 to 39.0 in 2007.
The overall annual growth of the incidence rate in the Dutch
population over 60 years, corrected for age and population size
was 1.78% (95% CI: 1.70–1.86) for males versus 1.47% (95% CI:
1.40–1.54) for females throughout the study period. A more
detailed examination of the incidence curve of ADR (joint point
regression analysis) revealed that the incidence growth has
changed over time and can be divided in two phases: the
incidence of hospital admissions due to an ADR increased strongly
between 1981–1996 (2.56%, CI 95%: 2.46–2.67) and the
percentage annual change slowed down between 1997–2007
(0.65%; CI 95%, 0.52–0.78). This flattening of the growth rate
remained significant after correction for age and population size
for both genders. Comparing 1986–1996 and 1997–2007, the
annual growth rate decreased from 2.80% (95% CI: 2.63–2.96) to
0.38% (95% CI: 0.18–0.59) in males and from 1.86% (95% CI:
1.73–2.00) to 0.90% (95% CI: 0.72–1.08) in females respectively
(p,0.001 for differences in slopes in both males and females).
Gender and age-specific incidence rates of ADR-related
hospital admissions increased in all age-groups, both for males
and females throughout the study period. All age-specific groups
for both genders showed an increase in incidence of ADR-related
Figure 1. Adverse Drug Reactions, annual number and age-
standardized rates per 10,000 persons aged $60 years in the
Netherlands, 1981–2007. Separate regression lines are fitted to the
period 1981–1996 (blue) and the period 1997–2007 (red). Solid lines
indicate regression lines fitted to data points for the corresponding
time period; dashed lines indicate the regression lines extrapolated for
the remaining time period. Error bars indicate the 95% confidence
interval.
doi:10.1371/journal.pone.0013977.g001
Table 2. Overall numbers of Adverse Drug Reactions related hospital admissions in the Netherlands (1981–2007).
Years 0–59 years % 60–69 years % 70–79 years % 80–89 years % $90 years % Total
Female:
Male ratio
1981–1985 17,913 36.2% 9,867 20.0% 13,239 26.8% 7,685 15.5% 742 1.5% 49,446 1:0.69
1986–1990 17,524 32.5% 10,998 20.4% 14,969 27.8% 9,235 17.2% 1,122 2.1% 53,848 1:0.74
1991–1995 19,400 30.8% 12,406 19.7% 18,064 28.6% 11,761 18.6% 1,434 2.3% 63,065 1:0.78
1996–2000 23,095 30.2% 14,064 18.4% 22,321 29.2% 14,960 19.6% 2,050 2.7% 76,490 1:0.72
2001–2005 25,278 30.8% 14,909 18.1% 22,641 27.5% 16,889 20.5% 2,473 3.0% 82,190 1:0.75
2006–2007 10,912 29.7% 7,255 19.8% 9,771 26.6% 7,595 20.7% 1,188 3.2% 36,721 1:0.75
Total 114,122 31.5% 69,499 19.2% 101,005 27.9% 68,125 18.8% 9,009 2.5% 361,760 1:0.74
doi:10.1371/journal.pone.0013977.t002
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males (Table 3), the largest (relative and absolute) increase in
incidence rates was seen in patients aged $90 years (162%, 95%
CI: 80–283), the absolute increase in incidence rate was 43.3 per
10,000 persons (95% CI: 21.3–75.8). For females (Table 3), the
largest increase was also seen in patients aged $90 years (112%,
95% CI: 66–169), the absolute increase was 37.2 per 10,000
persons (95% CI: 22.1–55.5).
The distribution of medication groups causing ADR changed
significantly (p,0.001) throughout the study period (Figure 2).
The contribution of cardiovascular agents (ICD-9: E942) to ADR-
related hospitalizations decreased from 36.0% in 1981 to 8.3% in
2007. Drugs affecting water, mineral and uric acid metabolism
increased (ICD-9: E944) from 5.4% to 15.4%, primarily systemic
agents (ICD-9: E933) increased from 3.2% to 24.4%, and agents
affecting blood constituents (ICD-9: E934) increased from 17.9%
to 24.2% between 1981 and 2007.
Approximately 45% of all ADR-related admissions were caused
by six diagnostic groups (bleeding, gastrointestinal symptoms,
anemia, cardiac symptoms, pulmonary symptoms, other) between
1991 and 2007 (Table 4). The distribution of admission diagnoses
shifted during the study period (p,0.001).
Discussion
This study shows that both the absolute numbers and the
incidence rates of ADR-related hospitalizations in persons aged
$60 years in the Netherlands increased strongly between 1981
and 2007. Although a slow down of the curve occurred in 1997,
the incidence rates since then are still increasing, albeit at a less
rapid rate. Of all ADR-related admissions, two-thirds were in the
age-group of 60 years and older. The increase occurred in both
males and females, although it was more pronounced in males and
in the higher age-groups. Drugs classes leading to ADR-related
hospitalizations shifted throughout the study period.
Our data represent an important first step in secular trend
analysis of ADR-related admissions in developed countries. As far
as we are aware from the literature, this study is the first to show a
deceleration in the increasing incidence rates of ADR-related
hospital admissions. Several factors may have contributed to this
finding. The deceleration in growth of ADR-related hospital
admissions started in the mid-nineties, after the introduction and
widespread use of personal computers and software, with
prescribing applications for doctors and pharmacists, which warns
for possible drug interactions and errors.[31,32,33] Furthermore,
due to professional publications and increasing media coverage,
since the mid-nineties awareness about ADR among both
professionals and the general public may have increased.[24,25]
Also standardized protocols and prescribing guidelines may have
contributed to this trend.[3] Other studies did not show the decline
in ADR-related hospitalizations, maybe due to their shorter study
period[8] or ending in 2002, before flattening of the incidence
rates of ADR-related hospital admissions had taken its full
effect.[19] Theoretically the slowdown in ADR-related hospital-
izations might also be (partly) caused by changes in admission
policy at the Emergency Departments. However, a survey among
Emergency Departments in the Netherlands[34] showed that the
proportion of patients presenting with an ADR, followed by
subsequent hospital admission, remained stable at 72% in the
Netherlands between 1998 and 2008.
A major strength of this study was the availability of very
accurate in-hospital data over an extensive period of 26 years
(1981–2007) with almost complete national coverage. Absolute
numbers of ADR-related hospital admissions in the Netherlands
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e13977were recorded in a computerized database, with the same coding
system (ICD-9) throughout the study period. This allowed us to
gather reliable population-based data for our trend analysis.
However, the data are only accurate within the limitations of the
coding system, which is likely to be dependent on the accuracy of
the data in the medical records and the recognition of ADR in the
first instance by the patient’s physician writing the record.
A number of limitations may have affected the interpretation of
our findings. First of all, diagnosis codes were taken from a linked
administrative database, which may be prone to coding errors and
variation.[35] However, a recent quality survey showed a high
accuracy of coded injury data (correctly coded in 91% of cases and
in 9% incomplete).[36] This provides support for the validity of
our data on ADR-related hospital admissions as extracted from
the LMR database, and is comparable to the registration in New
Zealand (period 1996–98).[37]
A second but unsolved limitation, however, is that the database
does not contain information regarding specific drug(s), medication
compliance, number of medications, co-morbidities, and clinical
details of the ADR. Therefore, it was not possible in this study to
draw conclusions regarding ADR details for specific drugs and
certain high risk groups, for example patients with polypharmacy.
Also, the database does not contain definitions of the ADR
according to the Naranjo[38] or other algorithms, so a distinction
between definite, probable, or possible ADR can not be made.
Third, we should take into account that underregistration of
ADR might have occurred, since ADR recognition is very
complex, especially in older adults, therefore ADR are not always
noticed by medical personnel.[39,40] For example, in older
persons, falls and delirium caused by drug-use are still under-
recognized as an ADR in current medical practice. For this
reason, it is likely that the actual societal impact of all ADR-related
morbidity, both mild and serious, exceeds the burden described in
our study.[7]
Fourth, this study is based on the national situation in the
Netherlands, with a full healthcare insurance coverage system and
Figure 2. The composition of drug groups causing Adverse Drug Reactions related hospital admissions in persons aged $65 years
in the Netherlands (1981–2007). The ICD-9 codes for Adverse Drug Reactions are shown. The main drug groups causing ADR-related admissions
are shown separately in this figure. *‘‘Other’’ drug groups were less frequently seen (,2% per group) and includes ICD-9 codes: E936-E338, E940,
E941, E943, E945, E946, E948 and E949. The distribution changed during the study (p,0.001, Chi
2-test).
doi:10.1371/journal.pone.0013977.g002
Table 4. Primary admission diagnosis for Adverse Drug Reactions related hospital admissions in patients $60 years in the
Netherlands (1991–2007).
1991 1994 1997 2000 2003 2006 2007
Bleeding 640 857 1,006 920 917 1,013 853
Gastrointestinal symptoms 349 442 446 491 527 549 513
Anemia 243 353 419 389 432 398 352
Cardiac system 398 513 564 452 433 435 377
Pulmonary system 123 191 290 329 390 474 486
Other 1,379 1,686 1,794 2,113 2,169 2,514 2,516
Hypoglycemic coma 617 692 456 384 399 359 332
Dehydration/Electrolyte Disturbance 183 239 381 497 637 791 721
Urinary Tract Infection 109 136 168 133 170 239 283
Bone/Cartilage disease 70 94 115 313 214 201 202
Agranulocytosis 58 97 142 191 198 317 364
Obstipation 174 232 306 355 355 394 433
Pulmonary embolism 168 196 226 240 196 213 181
Data on primary admission diagnoses were available since 1991. Chi
2-test for change in distribution of primary admission diagnosis was p,0.001.
doi:10.1371/journal.pone.0013977.t004
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comparable increasing time trends were found in England[8]
and Australia[19]. It therefore seems likely that the incidence of
hospital admissions due to ADR will progress similarly in other
developed countries.
In summary, drug prescription is a fundamental part of the care
of older persons. Adverse drug reactions are a known drawback of
medication use and represent an increasing public health problem,
especially among older persons.[10] Changes in demographics
alone cannot explain the increasing frequency of ADR and ADR-
related healthcare demand in an ageing society. Although we
found an encouraging decleration in the increasing trend of ADR-
related hospitalizations around 1997, the incidence rates contin-
ued to increase from 1997 onwards, therefore our attention to this
problem remains needed. Since ADR-related admissions have
been shown to be preventable in two-fifth of the cases,[11,13,20]
much is to be gained by further increasing the awareness among
healthcare professionals that symptoms in older patients may be
related to their drug use and by improving the ADR detection by
the use of an ADR Risk score in daily practice.[41]
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